5AM PARTNERS VII, LLC enters SKYE BIOSCIENCE, INC. with 1.13B shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 8/28/2023ACC: 0001209191-23-047511
10% Owner
Since Aug 2023
1.13B
Baseline shares
0.00
Direct ownership
0 positions
426.35M
Derivative underlying
1 instrument
3
Security positions
1.13B indirect
Non-Derivative Holdings3
Common Stock
IndirectShares owned429.55M
Common Stock
IndirectShares owned16.95M
Common Stock
IndirectShares owned684.36M
Total
1.13B indirect1.13B
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 429.55M | Indirect |
| Common Stock | 16.95M | Indirect |
| Common Stock | 684.36M | Indirect |
| Total | 1.13B | 1.13B indirect |
Derivative Holdings1
Warrant (Right to Buy)
IndirectUnderlying security
Common Stock
Underlying shares
426.35M
Shares owned
N/A
Exercise price
0.0206
Expiration
—
Exercise window
—
Total
Underlying
426.35M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Warrant (Right to Buy) Indirect | Common Stock | 0.0206 | — | — | 426.35M | N/A |
| Total | 426.35M | 0.00 | ||||